The median meth-HOXA9 level was 0% (range of 0–0.53%, n = 100) in donors and 0.7% (range of 0–46.6%, n = 48, p < 0.001) in lung adenocarcinoma patients (Figure 1). The gene discussed is HOXA9; the disease is lung adenocarcinoma.